|
1
|
Thrift AP and Whiteman DC: The incidence
of esophageal adenocarcinoma continues to rise: Analysis of period
and birth cohort effects on recent trends. Ann Oncol. 23:3155–3162.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim T, Grobmyer SR, Smith R, Ben-David K,
Ang D, Vogel SB and Hochwald SN: Esophageal cancer-the five year
survivors. J Surg Oncol. 103:179–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang S, Zhang G, Zheng W, Xue Q, Wei D,
Zheng Y and Yuan J: MiR-454-3p and miR-374b-5p suppress migration
and invasion of bladder cancer cells through targetting ZEB2.
Biosci Rep. 38:BSR201814362018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Ding N, Hu W, He J, Xu S, Pei H, Hua
J, Zhou G and Wang J: Down-regulation of BTG1 by miR-454-3p
enhances cellular radiosensitivity in renal carcinoma cells. Radiat
Oncol. 9:1792014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yisraeli JK: VICKZ proteins: A
multi-talented family of regulatory RNA-binding proteins. Biol
Cell. 97:87–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bell JL, Wachter K, Muhleck B, Pazaitis N,
Kohn M, Lederer M and Huttelmaier S: Insulin-like growth factor 2
mRNA-binding proteins (IGF2BPs): Post-transcriptional drivers of
cancer progression? Cell Mol Life Sci. 70:2657–2675. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vainer G, Vainer-Mosse E, Pikarsky A,
Shenoy SM, Oberman F, Yeffet A, Singer RH, Pikarsky E and Yisraeli
JK: A role for VICKZ proteins in the progression of colorectal
carcinomas: Regulating lamellipodia formation. J Pathol.
215:445–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huttelmaier S, Zenklusen D, Lederer M,
Dictenberg J, Lorenz M, Meng X, Bassell GJ, Condeelis J and Singer
RH: Spatial regulation of beta-actin translation by Src-dependent
phosphorylation of ZBP1. Nature. 438:512–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stohr N, Kohn M, Lederer M, Glass M,
Reinke C, Singer RH and Huttelmaier S: IGF2BP1 promotes cell
migration by regulating MK5 and PTEN signaling. Genes Dev.
26:176–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su Y, Xiong J, Hu J, Wei X, Zhang X and
Rao L: MicroRNA-140-5p targets insulin like growth factor 2 mRNA
binding protein 1 (IGF2BP1) to suppress cervical cancer growth and
metastasis. Oncotarget. 7:68397–68411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bando E, Makuuchi R, Irino T, Tanizawa Y,
Kawamura T and Terashima M: Validation of the prognostic impact of
the new tumor-node-metastasis clinical staging in patients with
gastric cancer. Gastric Cancer. 22:123–129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Ren X, Li L, Lu S, Chen T, Tan L,
Liu M, Luo Q, Liang S, Nie Q, et al: Integrative analyses of mRNA
expression profile reveal the involvement of IGF2BP1 in chicken
adipogenesis. Int J Mol Sci. 20:29232019. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lang B and Zhao S: miR-486 functions as a
tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
Oncol Rep. 39:71–80. 2018.PubMed/NCBI
|
|
19
|
Jung HK, Tae CH, Lee HA, Lee H, Don Choi
K, Park JC, Kwon JG, Choi YJ, Hong SJ, Sung J, et al: Treatment
pattern and overall survival in esophageal cancer during a 13-year
period: A nationwide cohort study of 6,354 Korean patients. PLoS
One. 15:e02314562020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W,
Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in
high-risk areas of China: Research progress and challenges. Ann
Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gomez-Gomez Y, Organista-Nava J and
Gariglio P: Deregulation of the miRNAs expression in cervical
cancer: Human papillomavirus implications. Biomed Res Int.
2013:4070522013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Riquelme I, Letelier P, Riffo-Campos AL,
Brebi P and Roa JC: Emerging role of miRNAs in the drug resistance
of gastric cancer. Int J Mol Sci. 17:4242016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu Y, Correa AM, Hoque A, Guan B, Ye F,
Huang J, Swisher SG, Wu TT, Ajani JA and Xu XC: Prognostic
significance of differentially expressed miRNAs in esophageal
cancer. Int J Cancer. 128:132–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao X, Ren T, Huang Y, Sun K, Wang S, Liu
K, Zheng B and Guo W: Knockdown of long non-coding RNA HOTAIR
increases miR-454-3p by targeting Stat3 and Atg12 to inhibit
chondrosarcoma growth. Cell Death Dis. 8:e26052017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shao Y, Liang B, Long F and Jiang SJ:
Diagnostic MicroRNA biomarker discovery for non-small-cell lung
cancer adenocarcinoma by integrative bioinformatics analysis.
Biomed Res Int. 2017:25630852017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin C, Lin T and Shan L: Downregulation of
calbindin 1 by miR-454-3p suppresses cell proliferation in nonsmall
cell lung cancer in vitro. Cancer Biother Radiopharm. 34:119–127.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5p suppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.PubMed/NCBI
|
|
29
|
Zhou X, Zhang CZ, Lu SX, Chen GG, Li LZ,
Liu LL, Yi C, Fu J, Hu W, Wen JM and Yun JP: miR-625 suppresses
tumour migration and invasion by targeting IGF2BP1 in
hepatocellular carcinoma. Oncogene. 35:50782016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fakhraldeen SA, Clark RJ, Roopra A, Chin
EN, Huang W, Castorino J, Wisinski KB, Kim T, Spiegelman VS and
Alexander CM: Two isoforms of the RNA binding protein, coding
region determinant-binding protein (CRD-BP/IGF2BP1), are expressed
in breast epithelium and support clonogenic growth of breast tumor
cells. J Biol Chem. 290:13386–13400. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stohr N and Huttelmaier S: IGF2BP1: A
post-transcriptional ‘driver’ of tumor cell migration. Cell Adh
Migr. 6:312–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qu Y, Pan S, Kang M, Dong R and Zhao J:
MicroRNA-150 functions as a tumor suppressor in osteosarcoma by
targeting IGF2BP1. Tumour Biol. 37:5275–5284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang J, Cheng J, Zeng Z, Wang Y, Li X,
Xie Q, Jia J, Yan Y, Guo Z, Gao J, et al: Comprehensive profiling
of novel microRNA-9 targets and a tumor suppressor role of
microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Oncotarget. 6:42040–42052. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qin X, Sun L and Wang J: Restoration of
microRNA-708 sensitizes ovarian cancer cells to cisplatin via
IGF2BP1/Akt pathway. Cell Biol Int. 41:1110–1118. 2017. View Article : Google Scholar : PubMed/NCBI
|
